FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Liraglutide Injection
Status: Currently in Shortage
»Date first posted: 07/18/2023
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Reverified 04/01/2024)

Company Contact Information:
833-493-4689

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)	Limited Availability	Estimated shortage duration TBD	Demand increase for the drug
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)	Limited Availability	Limited Availability through June 2024	Delay in shipping of the drug
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)	Limited Availability	Limited Availability through June 2024	Delay in shipping of the drug